CIBC analyst John Zamparo initiated Aphria (APHA) with a Neutral rating and C$10 price target. He expects cannabis to follow the course of other newborn industries, where investors rush to pour capital into the sector and then very few companies live up to their lofty expectations while the industries develop. The debate over the value of Aphria's international assets and corporate governance concerns have obscured the value of the company's quality domestic assets, but concerns about corporate governance and capital allocation are not without some validity, Zamparo tells investors. He also initiated coverage on two other cannabis stocks, Canopy Growth (CGC) and Cronos Group (CRON), both with Outperformer ratings this morning, citing his favorable view of their management teams.